Mesoblast Limited (MESO)

Mesoblast Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Revenue	7.25	7.5	10.21	7.43	32.16	16.72
Revenue Growth (YoY)	-10.69%	-26.54%	37.36%	-76.88%	92.30%	-3.57%
Gross Profit	7.25	7.5	10.21	7.43	32.16	16.72
Selling, General & Admin	23.58	25.37	27.21	30.87	25.61	21.63
Research & Development	26.41	27.19	32.82	53.01	56.19	59.82
Other Operating Expenses	16.15	23.48	31.29	31.16	24.99	15.69
Operating Expenses	66.13	76.05	91.32	115.04	106.78	97.13
Operating Income	-58.88	-68.55	-81.11	-107.6	-74.63	-80.41
Interest Expense / Income	19.76	20.12	17.29	10.71	14.11	12.08
Other Expense / Income	-5.39	-6.57	-6.81	-18.69	-1.38	6.26
Pretax Income	-73.25	-82.1	-91.59	-99.63	-87.36	-98.75
Income Tax	-0.19	-0.21	-0.24	-0.82	-9.42	-8.96
Net Income	-73.06	-81.89	-91.35	-98.81	-77.94	-89.8
Shares Outstanding (Basic)	814	737	650	647	537	499
Shares Change	25.17%	13.34%	0.39%	20.50%	7.75%	5.36%
EPS (Basic)	-0.91	-1.11	-1.41	-1.63	-1.47	-1.82
EPS (Diluted)	-0.91	-1.11	-1.41	-1.63	-1.47	-1.82
Free Cash Flow	-59.33	-63.53	-65.94	-102.4	-52.51	-58.07
Free Cash Flow Per Share	-0.73	-0.86	-1.01	-1.58	-0.98	-1.17
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-811.75%	-913.81%	-794.31%	-1447.44%	-232.07%	-480.86%
Profit Margin	-1007.28%	-1091.71%	-894.59%	-1329.18%	-242.38%	-537.01%
Free Cash Flow Margin	-818.02%	-846.99%	-645.76%	-1377.40%	-163.31%	-347.26%
EBITDA	-	-61.98	-74.3	-88.92	-73.25	-86.67
EBITDA Margin	-	-826.28%	-727.63%	-1196.07%	-227.78%	-518.32%
EBIT	-53.49	-61.98	-74.3	-88.92	-73.25	-86.67
EBIT Margin	-737.49%	-826.28%	-727.63%	-1196.07%	-227.78%	-518.32%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).